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Abstract: Hearing loss is a disease exhibiting a growing trend due to the number of factors, including but not 
limited to the mundane exposure to the noise and ever-increasing amount of older population. In the 
framework of a public health policymaking process, modeling of the hearing loss disease based on data is a 
key factor in alleviating the issues related to the disease issuing effective public health policies. First, the paper 
describes the steps of the data-driven policymaking process. Afterward, a scenario along with the part of the 
proposed platform, responsible for supporting policymaking are presented. With the aim of demonstrating 
the capabilities and usability of the platform for the policy-makers, some initial results of preliminary analytics 
are presented in a framework of a policy-making process. Ultimately, the utility of the approach is validated 
throughout the results of the survey which was presented to the health system policy-makers professionals 
involved in the policy development process in Croatia. 
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1. Introduction 
According to the Polityka Insight [1], “eHealth is the application of information and communications 
technologies across the whole range of functions that affect the health sector. This broad definition 
encompasses a variety of digital applications, processes, and platforms including electronic health record 
systems, TeleHealth (remote medical consultation), smartphone apps, remote monitoring devices and 
biosensors, computer algorithms and analytical tools to inform decision making”. The development of health 
policies can lead to ineffective and/or inefficient health systems posing a growing threat to a nations’ public 
health and economic stability, due to lack of use or consultation that is based on the best available research 
evidence. According to [20], the ultimate goal of a health system is promoting community health in an 
equitable manner, and as such evidence is required to enable policy-makersto assess the effectiveness of 
health policy in question. Consequently, ineffectiveness could be minimized by incorporating state-of-the-art 
information technologies into the process of policy-making, i.e., using evidence-based approaches suggested 
by researchers [2]. 
The Israeli researches found differences in the perceptions of knowledge producers and knowledge users on 
factors hindering the implementation of health policy and systems research, the accessibility of evidence to 
policy-makers, evidence credibility, and groups/factors influencing health policymaking [3]. Furthermore, in 
the United States of America, health models are simulated when working on health reforms, which usually 
results in creation of the accurate estimates for specific health policies [4]. Different public health issues are 
often dynamic and complex. Several approaches can be used in policy modeling of chronic disease prevention 
including specific factors as an ecological approach, disease outcomes, health and risk behaviors, 
environmental factors, health-related resources, and delivery systems [5]. Mathematical modeling is a key 
issue when dealing with disease prevention. Metcalf et al. [6] described six challenges between modeling and 
public health: C1. Communicating the limits of modeling, C2. Maintaining the value of models in the face of 
  
long-time horizons, C3. Usefully deploying modeling in the context of ‘black swans’, C4. Integrating modelers 
and model-building into the policy process, C5. Economic analysis and decision support, C6. Creating a cycle 
where results inform decisions and vice versa. Models are described and developed as computational versions 
of laboratory experiments and using available data. That kind of approach can be used when searching for 
answers on policy questions. The final results of policy modeling should be transparent and easy to replicate 
[7] Phases of the policymaking process are described by Dunn [8] as cycles of Agenda Setting, Policy 
Formulation, Policy Adoption, Policy Implementation, Policy Assessment, Policy Adaptation, Policy Succession, 
and Policy Termination. 
There is a number of projects and papers that try to address the policymaking challenges. The research project 
‘EVidence-based management of hearing impairments: public health policymaking based on fusing big data 
analytics and simulaTION’ (EVOTION) [9] aims to build the evidence base for the formulation of public health 
policies related to the prevention, early diagnosis, long-term treatment and rehabilitation of hearing loss (HL), 
as well as to the detection and prevention of cognitive decline and the socio-economic inclusion of individuals 
with HL. Its objective is to enable and support more holistic management of HL1. In the other words, even 
though it has potential uses in the other health sectors, EVOTION is specifically tailored for addressing HL-
related issues and policy making. HL is a disease with the increasing prevalence, and it will increase due to 
increasing exposure to noise and an increase in the aging population. Anisetti et al. [10] [11] [12] use a big 
data platform to identify the behavior of interest and deontic logic in order to design a data-driven model for 
policymaking that can be updated over time. Prasinos et al. [13] propose a model-based approach presenting 
a platform for policy-makers in the context of HL related policies. This platform is based on high-level language 
for the specification of evidence-based health policy and decision-making models based on big data analytics. 
In this paper, we propose a platform to support data-informed policymaking. 
According to Innvaer et al. [14], “the empirical basis for theories and common wisdom regarding how to 
improve appropriate use of research evidence in policy decisions is unclear. One source of empirical evidence 
is interview studies with policy-makers”. In this paper, we first describe the data-informed policymaking 
process. We then present a platform capable to support such a process and address the above challenges (C1-
C6) and then present some preliminary walkthroughs of its usage. In addition, as a way to evaluate the value 
of the approach from a policymaking perspective, we present a survey to find out what experts, who are 
involved in creating public health policies and making decisions, think about e-Health and the platform we 
proposed. 
2. The Data-informed Policymaking Platform 
Our policymaking platform is an analytics-as-a-service platform based on the TOREADOR [15] methodology 
and fine-tuned for the needs of policy-makers. It allows the use of fully parametric predefined analytics 
(analytics workflows) to be tailored to specific needs, as well as building analytics from scratch combining 
analytics methods (analytics tasks) into a workflow following the approach in [10]. 
In this section, we first describe the data-informed policymaking process, that we present our platform 
supporting this process. 
2.1. The Policymaking Process 
In the framework of defining a health policy, policy-makers are normally assisted by domain experts that rely 
on previous scientifically validated results to be used to support a specific policy decision. Unfortunately, 
scientifically validated results are not always available/suitable for all the situations. For instance, in 
emergency situations, as it happened with COVID-19 pandemic, many collateral aspects including health and 
economic aspects have to be taken into consideration. When well-established the literature or well known 
best practices are not available the policymaking process is much more complex and normally less effective 
requiring time and multiple refinement iterations. This paper presents a platform that can assist policy-makers 
to retrieve the evidence they need in order to take an effective and rapid decision on specific policy action. 
This platform allows access to a set of analytical capabilities that, when associated with a data lake where data 
relevant for the domain of the policy is continuously fed can allow retrieval of the evidence needed for a policy 
release on a specific domain. This means that a simulation can be run on the already existing data, which can, 
as a result, provide insights about how a certain policy recommendation can impact the study population. 
                                                             
1 EVidenced based management of hearing impairments: Public health pΟlicy making based on fusing big data analytics and 
simulation (EVOTION). Available online: http://h2020evotion.eu/ 
  
In this paper, we assume a scenario where all the relevant data needed for a specific domain is available (e.g., 
open data or validated medical longitudinal study). 
We also assume as normal in case of policymaking that the policy-maker is assisted by a domain expert while 
setting up a policy. In our case, this domain expert is also a data scientist capable to select among the available 
analytics offered by the platform or to compose them into new ones. 
Figure 1 shows the methodological view of our data-informed policymaking process. In the framework of 
retrieving evidence for defining a required policy, policy-maker can interact with the platform front end with 
the assistance of a domain expert. The interaction is aimed to triggers analytics on a data lake that is relevant 
for the policy (e.g., clinical data form COVID patients). When executed the analytics provides results that have 
to be aggregated into meaningful evidence to be provided to the policy-makers. The platform can also be used 
by a domain expert to validate the data in the data lake (e.g., statistical validity, coverage, etc.) Normally 
validation is the preliminary step in order to be sure that the dataset is informative enough to derive 
meaningful results. 
 
Figure 1. Data-Informed Policymaking Methodology. 
While interacting with the platform front end the policy-maker fulfills a data-informed policymaking process 
that according to [10] and [11] is based on a sequence of steps: Situation Analysis: the preliminary stage where 
the policy-makers decided how to proceed and draft the policy to be refined and validated in the following 
stages. 
Action Plan: Traditionally this consists of selecting patients for a trial. In the scenario of policymaking driven 
by data, this is equivalent to selecting data from the available set on one side and enrolling additional patients 
on the other (i.e., selecting patients). 
Implementation Evaluation and Monitoring: The policy is released as a recommendation and later moved to 
prescription in case of successful verification of the validity. This means that the data still being collected from 
the set of enrolled patients in order to see the impact of the policy. Monitoring could be a long-time process 
where the policy is monitored in order to see if some fine-tuning is required or not. 
 
Figure 2. Data-Informed Policymaking process. 
Depending on the outcome of this stage the policymaking process can be also partially or completely re-
executed from situation analysis or from the action plan stage. Each stage of the data-informed policymaking 
process requires different types of analysis. 
  
Figure 2 shows our data-informed policymaking process connected to the analytical activities that are 
requested to support each of the policy stages. 
During the Situation analysis step, the policy-makers can i) analyze what has been done in literature for the 
aspects they want to take care of and for instance identify which features have been considered in similar 
situations and why, and ii) do some preliminary analysis on the distribution and correlations of these 
important features to envision how to proceed further. They can also add other features that have not been 
considered in literature in order to see if they are relevant or not. At this stage, the analysis is of descriptive 
type, like aggregation functions and simple statistical analysis. 
During Action plan step the policy-maker can (i) given the preliminary results set up the predictive analytics 
that will support the policy, (ii) verify with the preliminary collected set of data and the historical data the 
validity of the prediction and, (iii) define the policy. At this stage, the analysis is of predictive type, like machine 
learning approaches for classification, prediction and pattern identification. 
During the Implementation Evaluation and Monitoring step, the effect of the policy will be monitored using 
simulation, optimization and prediction capabilities. This stage of analysis is of a prescriptive type. Moreover, 
the focus of this stage lies in performing fine-tuning and optimization, as well as for deciding whether the 
discrepancy between what is predicted and what actually occurred requires further refinement at Action plan 
or Situation analysis stages. 
2.2. The Platform 
Our platform supports the methodology in Figure 1 and the above policymaking process in Figure 2. It is 
constituted by a number of components. 
 
Figure 3. Platform Components. 
Figure 3 shows the principal platform components. More in detail the Analytics backend is an evolution of the 
big data engine in [16] that builds on Apache Framework i.e., HDFS, Hadoop, and Spark just to name the few, 
enabling processing of a large amount of data. The need for such big data platform, considering the 5v 
definition, is due to the nature of the policymaking analytics that spans over a population of a region or entire 
country (i.e., volume). It includes different sources and formats (i.e., variety), concerning in most of the cases 
data trustworthiness and sensibility (i.e., value, veracity). Occasionally when the policy is in the monitoring 
stage it is able to process incoming new data from the policy application in order to monitor the effectiveness 
(i.e., velocity). 
In order to support the policymaking process the Apache platform is enriched with two catalogs that offer 
analytical capabilities to policy-makers: 
• Analytics task catalog: A catalog of analytics tasks offered by the platform. For instance, statistical 
analyses, feature selections, but also K-means clustering, KNN model and prediction just to name a few. 
The analytics tasks are designed to be composed into workflows and are based on the available mllib 
library for Spark2 and ad hoc processing tasks. 
• Analytics workflows catalog: A catalog of workflows that can be triggered to perform the analysis. The 
workflows are orchestrated with Oozie. 
The Platform front-end provides a graphical interface for the policy-maker to i) select between the available 
workflows, choosing parameters, like the specific data source to be used, or ii) build new ones composing 
available tasks into workflows. 
While composing a new workflow the policy-maker is guided by the platform in order to produce a valid 
workflow by design. The guide is constituted by a set of template workflows to be fed with analytics tasks. 
Some examples of template workflows include modeling workflows, which can be used to generate a machine 
learning model via training and prediction template which can be used to perform a prediction based on a 
  
specific model. There are also preprocessing template workflows that can be used for feature selection, data 
cleaning, normalizations, etc. The template approach is much more generic than the parametrized workflows 
since it allows policy-maker to choose between a number of different analytical algorithms available in the 
task catalog and combine them in case of necessity or compare them. 
For each step of the workflow creation, the relevant available tasks for a specific template are shown to the 
policy-makers as well as all the required parameters to be decided. 
In order to support this process, the front end it is composed of the following sub-components 
• GUI: The graphical interface where the policy-maker can easily select and parametrize available 
workflows or build a new one with a wizard-like assisted interface. 
• Transformation service: Transforms the workflows generated at interface level into executable ones 
building the required glue into Oozie workflows. It first checks that it is valid and then transform it. 
Our platform covers the requirements listed in the introduction (C1..C6). 
The process implemented by the platform is mainly driven by the data as well as by the analytics model and 
required policies for data processing. This allows the comparison and selection of the most representative 
model to be used in relation to a specific policy (C1, C4). The results of the policy model executions are saved 
in the database and maintained for future use and comparison (C2). The platform is capable of executing 
predictions in a timely manner and supporting predictions in the emergency, and not expected situation (C3). 
Furthermore, the platform can be used as a means to support the decision of the policy-makers providing 
evidence and can be extended to take care of the economics connected (C5). Finally, the platform also fosters 
a refinement cycle where results can be used for additional analysis until it converges to a policy intended for 
release (C6). The policy-maker can schedule the execution of each workflow and be notified when the 
execution completed. 
Policy-makers can also see the list of all previously executed workflows along with their execution status and 
in case of necessity, they can re-execute them. For each executed workflow the domain expert can see more 
advanced details like the graphical representation of the workflows, including their building blocks (tasks), as 
well as logs, intermediate results and specified configurations for each of the building blocks. 
Once the desired workflow has been successfully executed, it is saved to the database (i.e., HDFS). Afterward, 
a policy-maker can choose to use the saved data in the framework of another analysis or visualize the results 
through the means of front end GUI. Furthermore, a policy-maker can select the desired visualization option, 
such as a histogram or line chart and a resulting dataset, and fill the required input parameters in order to get 
a better perception of the produced results. 
3. The Hearing Loss Scenario 
In this paper, we consider a hearing loss (HL) policy scenario of the h2020 EVOTION project where a trial with 
a significant population of HL patients has been selected and equipped with hearing aids (HA) devices in order 
to study their subjective satisfaction as well as significant changes to the HA usage data been produced, in the 
context of the policymaking process. More specifically the trial includes around 1000 subjects that had been 
fitted with HA devices and monitored for one year. The dataset contains subject data including age, education 
level, and a set of results of medical tests carried out during the fitting visits and the periodical follow-up visits. 
The dataset also consists of more advanced parameters related to the degree of hearing loss in each ear, such 
as the combined hearing loss level for both ears and measure of the MOCA (Montreal Cognitive Assessment) 
test, as well as of details regarding HA usage and the relative parameters (average usage per day for instance). 
For the sake of this paper, since we are just demonstrating the platform utility and not scientific relevance of 
the analysis carried out, the data used was synthetically generated starting from the EVOTION trial dataset 
following the approach of Christensen et al. [17] which permits preservation of the privacy and maintenance 
of the statistical significance. The policy’s goal that we are considering is to minimize/lower the dropout rate, 
i.e., number of the patients who withdrew from the study prematurely, from the clinical study predicting 
dropping out factors with the aim of effective intervention or as a way of planning a better subject selection 
to minimize the number of dropouts. The dropout from a study is physiological, and in many situations may 
cause a number of issues related to the effectiveness of the study. There is a set of potential causes that can 
lead patients to drop out of the study. These factors have to be thoroughly scrutinized in order to elucidate 
the factors which could lead to the deterioration of the overall study quality and which can help in the future 
prediction of patients or groups of patients that are under the risk of leaving the study prematurely. 
  
This scenario poses challenges from a medical and technical perspective, since the HL pathologies deeply 
depend on the subject behavior and also HL has been shown to have a significant societal impact. From the 
policymaking point of view is therefore very representative. 
4. Preliminary Evaluation 
In this section, we first present some preliminary policymaking results applied to the scenario in Section 3 
describing a walkthrough example. Secondly, to evaluate the utility of the approach from the policy-maker 
perspective, we first presented the platform to the policy-makers and then surveyed. 
4.1. Policymaking Platform: a Walkthrough Example 
The following walkthrough describes the process of policymaking with the goal of reducing the dropout rate 
(see the scenario described in Section 3). Even though the platform supports the entire process, for the sake 
of conciseness we concentrated on the Situation analysis and Action plan only, leaving the monitoring stage 
for future works. 
4.1.1. Situation Analysis 
Let us consider the situation analysis step of the policymaking process, a policy-maker first tries to inspect the 
current literature about the factors affecting the dropout rate in the context of HL. Using our platform, the 
policy-maker can see if the features that come from the literature are available in the data lake connected to 
the platform or if they can be calculated starting from what is available. For instance, if one feature that is 
relevant in the literature related to the scenario of this walkthrough is the total usage of the HA device per 
month, but the dataset contains just the timestamp where the HA device has been turned on and off by a 
given subject, there is the need to compute the usage time as the sum of these periods for each subject for a 
month. The platform supports policy-makers in doing these preliminary analyses offering all the pre-
processing capabilities requested. The policy-maker can combine analytics tasks into workflows to perform 
the data pre-processing. 
Having done the pre-processing workflow, the policy-makers can use the computed total HA usage (6262105 
records in our case for all the 1000 subject of the trial) to carry out two critical trends analyses that have been 
shown and that are correlated to the dropout rate of the patients, namely: 
• Average HA usage among the entire population grouped by the participants’ age for each month since 
the fitting date. 
• Average HA usage among the entire population grouped by the participants’ education level age for each 
month since the fitting date. 
In the first group the participants have been divided into several groups according to their age and overall 
distribution in each group, including (i) participants younger than 35 years; (ii) participants between 35 and 
45 years old; (iii) participants between 45 and 55 years old; (iv) participants between 55 and 65 years old; (v) 
participants between 65 and 75 years old; (vi) participants older than 75 years. 
Similarly, participants are divided into three groups according to their education level, namely: 
• Participants having low education level (participants that have spent eight or fewer years in education, 
i.e., equivalent to elementary school); 
• Participants having medium education level (participants that have spent between 9 and 14 years in 
education, i.e., equivalent to the secondary education); 
• Participants having high education levels (participants that have spent 14 or more years in education, 
i.e., equivalent to the University degree). 
The results of analyses of these two trends are shown in figures 4 and 5, which can be seen below. 
  
 
Figure 4. Average HA usage per age group per month. 
 
Figure 5. Average HA usage per age group per month. 
As it can be observed from the given Figure 4, the results indicate that the older participants, aged from 65 to 
75 years, have been using HA device the most consistently throughout investigated time, followed by the 
group of patients aged 75 years or more and 55 to 65 years old. On the other hand, younger (below 35 years 
old) and middle-aged participants (45 to 55 years old) show a similar, significantly lower trend of HA usage. 
Participants aged from 35 to 45 years old tend to be the riskiest group when it comes to the odds of dropping 
out, being constantly at the bottom of average HA usage. Moreover, it can be indicated that the participants 
belonging to this age group exhibit a gradual decrease in HA usage during the time. 
Figure 5 demonstrates the average HA usage per education level group during the course of the time. Highly 
educated participants show both the best progress, i.e., constant growth of HA usage, except for the last 
month, as well as the highest average HA usage over the examined period. The second group of the 
participants, i.e., participants having a medium level of education exhibit the highest HA usage in their starting 
month; however, as time passes slower growth and stagnation can be indicated in their HA usage. Lastly, 
participants having lower education levels exhibit a lot of oscillations in their average HA usage. Thus, this 
group of participants can be considered to be most likely under the risk of dropping out from the further study. 
Results of the showcased analyses suggest that highly educated patients, aged 65 to 75 years are the safest 
group for the study. Figure 6 indicates a comparison of the average HA usage of this group compared to the 
average HA usage of the remaining participants. 
  
 
Figure 6. Comparison of average HA usage of the highly educated participants aged 65 to 75. 
As it can be observed from the given figure, the very positive trend of HA usage and overall high average usage 
time can be observed for this given group. 
The performed analyses reveal some of the essential trends that could be utilized by policy-makers in order 
to aid them in deciding on which groups of participants they should focus on future studies. These analyses 
concluded the Situation Analysis stage of the policymaking process. They give ideas on how to proceed with 
the other stages for which our platform provides prediction and simulation capabilities. In this case, for 
instance, it seems that old and highly educated patients do not drop out on average. 
This evidence will be used in the next stages to tune the analysis and decide the dropout prediction analytics 
to be used and the features to be considered. 
4.1.2. Action Plan Stage 
On action plan, based on the preliminary results (in terms of features and corresponding correlations), the 
policy-makers can select the most suitable analysis approach for achieving the policy goal among the available 
approaches suggested by the platform. In the case of our scenario, the goal is to predict dropout in order to 
see what is impacting it and release a policy capable of selectively preventing the dropout. In this walkthrough, 
we show how the policy-maker adopts a trial and error approach in order to find suitable analytics for its goal. 
Given the analysis on the previous policymaking stage, the policy-makers selects the following features 
available in the data set of our scenario that show a certain degree of correlation with the dropout: 
AVG_HA_USAGE (Average Hearing Aids Usage), TOTAL_HA_USAGE (Total Hearing Aids Usage), 
VARIANCE_HA_USAGE (Variance Hearing Aids Usage), TOTAL_SCORE (MOCA MENTAL Score), AGE (Patient’s 
Age), HI_DEGREE_CURRHL_L (Degree of Hearing Loss in the Left Ear), HI_DEGREE_CURRHL_R (Degree of 
Hearing Loss in the Right Ear), HEARING_LOSS_SEVERITY (Combined Hearing Loss Level for Both Ears), 
EDUCATION_LEVEL (Education Level). 
In addition, since the entire dataset was labeled for the dropout, the policy-maker also selects the 
classification label called DROPOUT(1: Dropout, 0: Non-dropout) as the label, for the list of known dropout 
patients, as well as for the other patients which are still in the study. In order to reduce the bias and deal with 
the class imbalance, the number of records containing non-dropout users was reduced to the same number 
(134 records for each label) as the number of available patients marked as dropouts. 
For demonstrating prediction capabilities of our platform, three different classification algorithms, namely 
Decision Tree Classification, Logistic Regression and Support Vector Machines (SVM) were selected. 
Afterward, the previously selected dataset was randomly split into training and testing datasets by using three 
different ratios: 70:30 (i.e., 70% training and 30% testing), 60:40 (i.e., 60% training and 40% testing), and 50:50 
(i.e., 50% training and 50% testing). Furthermore, for the purpose of this demonstration four features out of 
the list of available features were selected, including AVG_HA_USAGE, VAR_HA_USAGE, AGE, and 
EDUCATION_LEVEL. Accordingly, models for Decision Tree Classification, Logistic Regression and SVM were 
  
created for all training sets. Moreover, decision tree classification was built using the default parameters, 
whereas SVM and logistic regression model parameters were tuned in order to boost their performance. 
Table 1. Performance evaluation of the different classification algorithms on varying training/test sizes. 
Algorithm 
50:50 60:40 70:30 
TP FP TN FN TP FP TN FN TP FP TN FN 
SVM 57 2 68 7 40 0 55 11 32 16 23 5 
Logistic Regression 61 25 45 3 47 6 49 4 33 13 26 4 
Decision Tree Classification 62 1 69 2 49 5 50 2 36 1 38 1 
Afterward, predictions were made on the corresponding test datasets, while in the case of the model trained 
on the entire dataset, the prediction was also calculated on the whole dataset. 
In Table 1 the performance of each algorithm is summarized. In the terms of correctly predicting dropout 
cases (TP), it can be seen that Decision Tree Classification performed the best in all three cases (correctly 
predicting 62 out of 64, 49 out of 51 and 36 out of 37 dropouts cases in 50:50, 60:40 and 70:30 dataset splits 
respectively), while SVM performed the worst in all three cases (correctly predicting 57 out of 64, 40 out of 
51 and 32 out of 37 dropout cases in 50:50, 60:40 and 70:30 dataset splits respectively). Furthermore, when 
it comes to correctly predicting non-dropouts (TN), Decision Tree Classification again maintained the best 
overall performance, by having the highest performance in two out of three cases, namely 50:50 and 70:30 
splits with 69 out of 70 and 38 out of 39 correctly predicted labels respectively. In the case of 60:40 dataset 
split, SVM outperformed Decision Tree Classification by correctly predicting all cases (55) compared to 50 
correctly predicted cases by Decision Tree Classification. 
Consequently, precision, recall, and f-measure results are shown in Figure 7. It can be observed, Decision Tree 
Classification performed the best in all three cases in terms of recall and f-measure, as well as in two out of 
three cases in terms of precision. On the other hand, Logistic Regression and SVM algorithms had a 
comparable performance, which was in turn significantly lower than the performance of Decision Tree 
Classification. This is especially the case in the third use case, where the dataset was divided according to the 
ratio 70:30. Performance drop can be potentially attributed to the fact that the further parameter tuning for 
those models is required. As a matter of fact, due to the ease of use and high performance, for this specific 
use case decision tree classification is a recommended classification algorithm of choice. 
 
Figure 7. Comparison of precision, recall and f-mesure performance of different classification algorithms on varying 
training/test sizes. 
  
By following the given use cases, a policy-maker can utilize the same algorithms on any combination of the 
available features, as well as perform the further parameter tuning in order to achieve the desired 
performance. 
4.2. Utility Analysis: Survey 
We have created a survey in order to inquire into the opinions of experts taking part in developing public 
health policies, regarding the application of new technologies and the platform, as far as the approach to hard-
of-hearing persons is concerned. Policy-makers as target population were randomly selected from three 
different institutions. The survey was conducted at (a) the Croatian Institute of Public Health, whose experts 
propose measures to preserve and improve people’s health, (b) the Croatian Ministry of Health, that make 
decisions on the proposal of the Croatian Institute of Public Health, and (c) the Croatian Chamber of Health 
Professionals, which also cooperates with the Ministry of Health. 
The research was conducted by the Institute of Public Health for the Osijek-Baranya County during April 2019. 
We used a questionnaire survey. Information about the EVOTION project was provided at the beginning of 
the questionnaire. The targeted population in the conducted research was a group of health policy-makers. 
We used purposive sampling methods. There were 38 respondents for the survey. The questionnaire consisted 
of 21 questions. 17 questions were related to the awareness of the respondents about the existence of the e-
Health strategy in Croatia, the availability of healthcare applications and the benefits they bring, as well as 
their views on the Platform. Basic demographic-related questions were included. The last four questions 
concerned the demographic traits, which included the gender composition of respondents, the age group 
(younger and older than 40 years old), the type of employment and the educational level. Questions from the 
MARS questionnaire for the evaluation of Health Mobile Apps [18] and Third Global Survey on e-Health 20152 
were adopted and used. Also, some questions were used from an E-Health Questionnaire for the Czech 
Republic 20133. The questionnaire included closed, multiple-choice and Likert-scale-styled questions [19]. 
4.2.1. Statistical Analysis 
The results are shown in contingency tables. Software SPSS (ver. 16.0, SPSS Inc., Chicago, IL, USA) was used 
for the analysis. 
Table 2. Respondents by sex and age group. 
age 
M F all 
N (%) N (%) N (%) 
<40 9 (52.9) 12 (57.1) 21 (55.3) 
≥ 40 8 (47.1) 9 (42.9) 17 (44.7) 
all 17 (100) 21 (100) 38 (100) 
Table 3. Choose the highest level of your education. 
level of education 
M F all 
N (%) N (%) N (%) 
undergraduate study 1 (5.9) 0 1 (2.6) 
graduate study 16 (94.1) 21 (100) 37 (97.4) 
all 17 (100) 21 (100) 38 (100) 
38 respondents took part in the survey, 17 (44.7%) men and 21 women (55.3%). Most of the respondents 
(55.3%) are younger than 40. 97.4% of the respondents have a high degree of education (University study) 
(Tables 2 and 3). 
  
                                                             
2  World Health Organization. 2015. Third Global Survey on eHealth. Available online: 
https://www.who.int/goe/survey/goe_2015_survey_en.pdf 
3 E-Health Questionnaire for Czech Republic 2013. Available online: https://www.surveymonkey.com/r/LS2Q95L 
  
Table 4. What should be the primary measurable objectives of an e-health system? (you can answer more than one). 
Objective  
yes no don’t know all 
N (%) N (%) N (%) N (%) 
Does your national universal health coverage policy or strategy clearly refer 
to the use of ICT or eHealth to support universal health coverage? 
16 
(42.1) 
10 
(26.3) 
12 
(31.6) 
38 
(100) 
Does your country have a national eHealth policy or strategy? 24 (63.2) 
4 
(10.5) 
10 
(26.3) 
38 
(100) 
Does your national eHealth policy or strategy refer to the objectives of 
universal health coverage or its key elements? (such as access, quality and 
cost of care) 
13 
(34.2) 
5 
(13.2) 
20 
(52.6) 
38 
(100) 
Does your country have a national health information system (HIS) policy or 
strategy?  
25 
(65.8) 
13 
(34.2)  
38 
(100) 
Are you aware of the availability of health apps (applications) for 
smartphones?  
30 
(78.9) 
8 
(21.1) - 
38 
(100) 
Are you aware that noise can have a harmful impact on health?  38 (100) - - 
38 
(100) 
9. Do you find this Platform usefull?  37 (97.4) 1 (2.6) - 
38 
(100) 
Do you feel that this approach is more successful in prevention and the 
management of hearing loss?  
27 
(71.1) - 
11 
(28.9) 
38 
(100) 
 
42.1% of the respondents said that the national health coverage policy or strategy clearly refers to the usage 
of ICT or eHealth to support universal health coverage. 26.3% of respondents think that this policy is unclear, 
and 31.6% of respondents do not know. 63.2% said that the country has a national eHealth policy or strategy, 
10.5% of the respondents said it does not, and 26.3% of the respondents do not know. When asked “Does 
your national eHealth policy or strategy refer to the objectives of universal health coverage or its key 
elements?” (such as access, quality, and cost of care), 52.6% said that they do not know, 34.2% said that the 
national eHealth policy or strategy refers to the universal health coverage objectives or its key elements, and 
13.2% of the respondents said that the policy or the strategy do not refer to these objectives. 65.8% of the 
respondents said that the country has a national health information system policy or strategy, whereas 34.2% 
said that it does not. 78.9% of respondents are aware of the availability of health apps for smartphones. All 
respondents are aware of the harmful impact that noise can have on health. 97.4% of the respondents said 
that the platform was useful. 71.1% of the respondents said that this approach is successful in hearing loss 
prevention and management strategy. 28.9% said they do not know. 
Table 5. What should be the primary measurable objectives of an e-health system? (you can answer more than one). 
Objective 
yes no all 
N (%) N (%) N (%) 
cost saving   30 (78.9) 8 (21.1) 38 (100) 
quality control  29 (76.3) 9 (23.7) 38 (100) 
improvment of health outcomes  24 (63.2) 14 (36.8) 38 (100) 
development of new products and services  14 (36.8) 24 (63.2) 38 (100) 
easier patient access to care 2 (5.3) 36 (94.7) 38 (100) 
all 17 (100) 21 (100) 38 (100) 
 
Respondents believe that primary measurable objectives of an e-health system should be: cost saving (78.9%), 
quality control (76.3%), improvement of health outcomes (63.2%), development of new products and services 
(36.8%) and easier patient access to care (5.3%) (Table 5).  
  
Table 6. What type of applications do you download? 
Applications 
yes no all 
N (%) N (%) N (%) 
games 9 (23.7) 29 (76.3) 38 (100) 
education 14 (37.8) 23 (62.2) 37 (100) 
books 9 (23.7) 29 (76.3) 38 (100) 
news 13 (34.2) 25 (65.8) 38 (100) 
social  19 (50.0) 19 (50.0) 38(100) 
health and lifestyle 16 (43.2) 21 (56.8) 37 (100) 
business 12 (31.6) 26 (68.4) 38 (100) 
other 7 (18.9) 30 (81.1) 37 (100) 
all 17 (100) 21 (100) 38 (100) 
 
Most of the respondents download social apps (50%), health and lifestyle (43.2%), education apps (37.8%), 
then news (34.2%), business apps (31.6%), games & books app (23.7%) and other (Table 6). 
 
Figure 7. “Would you recommend this platform to people who might benefit from it?”. 
Most of the respondents (39.5%) said they would recommend the platform to some people, and 36.8% of the 
respondents believe there are many people to whom they would recommend the platform. 18.4% of the 
respondents would recommend such a platform to everyone, and 5.3% would not recommend it to anyone. 
  
 
Figure 8. “How many times do you think you would use this platform in the next 12 months if it was relevant to you?”. 
In the next year, 34.2% of the respondents would use the app 1-2 times, 28.9% of the respondents would use 
the platform 3-10 times, 21.1% respondents would use the platform 11-50 times, and the percentage of 
respondents who would not use the platform at all is the same to the percentage of respondents who would 
use it more than 50 times (7.9%) (Figure 8). 
Table 7. Please tick the box that best describes what you think “e-health improve quality of service“. 
Improvements  
strongly 
agree agree neutral disagree 
strongly 
disagree all 
N (%) N (%) N (%) N (%) N (%) N (%) 
Please tick the box that best describes what 
you think. „e-health improve quality of 
service“ 
12 (31.6) 18 (47.4) 
7 
(18.4) 1 (2.6) - 
38 
(100) 
„e-health solutions improve health care 
outcomes“ 10 (26.3) 19 (50) 
7 
(18.4) 1 (2.6) -  
„e-health is important for creating new health 
care products and services?“ 12 (31.6) 
20 
(52.6) 
6 
(15.8) - -  
 
31.6% of the respondents think that e-health improves the quality of service, 47.4% has a neutral stance 
toward the statement, whereas 18.4% of the respondents do not agree and 2.6% strongly disagree with the 
statement. 26.3% of the respondents think that e-health improves health care, 50% are neutral, 18.4% think 
it does not improve health care, and 5.3% of the respondents strongly disagree with the statement. 52.6% of 
the respondents agree with the statement that e-health is important for creating new health care products 
and services, 31.6% strongly agree, and 15.8% are neutral (Table 7). 
  
 
Figure 9. “Would you pay for our platform?”. 
As it can be observed from the Figure 9, 50% of the respondents said they would not pay to use the app, 18.4% 
would not pay, the percentage of respondents who would pay is the same to the percentage of respondents 
who are neutral (13.2%), whereas 5.3% said they would pay to use the app. (Figure 9 
4.2.2. Discussion on survey results 
As far as the ICT is concerned, 42.1% of the respondents said that the national health coverage policy or 
strategy clearly refers to the usage of ICT or eHealth to support universal health coverage. Due to the 
percentage of respondents who think that the policy is unclear (26.3%) and those who do not know the answer 
(31.6%), the question arises as to how well the respondents are informed about and familiar with the national 
policy and health insurance strategy, as well as how aware they are of the connection between this strategy 
with ICT and e-health. Even though informatization and the introduction of e-Health have been done for the 
past 10 years 4, 10.5% of the respondents said the country does not have a national e-Health policy or 
strategy, and 26.3% does not know whether such a policy or strategy exists. 52.6% of the respondents do not 
know and 13.2% of the respondents think that the national e-Health policy or strategy does not refer to the 
objectives of the universal health coverage or its key elements (e.g., access, quality, cost of care). More than 
a third of the respondents (34.2%) think that the country does not have a national health information system 
policy or strategy. Acquired data is concerning if we take into account that policy-makers from three key 
institutions participated in the survey (Croatian Institute of Public Health, Croatian Ministry of Health and the 
Croatian Chamber of Health Professionals). It might be the result of a lack of human resources policies focusing 
on expertise and competences, while insufficient staff education is prevalent. Further research should 
certainly clarify this issue. In Lavis’ study [20], over a third of researchers did not feel that their country’s health 
research environment was supportive of individuals undertaking knowledge translation activities (37%) and 
nearly half (47%) did not feel that there were sufficient structures and processes in place to link researchers 
and their target audience. The respondents from our survey think that the primary measurable objectives of 
an e-Health system should be: cost-saving, quality control, improvement of health outcomes, development of 
new products and services and easier patient access to care. One-third of respondents think that e-Health 
improves the quality of service. Only 26.3% of respondents think that health care is improved by e-Health. 
More than half of the respondents recognize the potential of e-Health in developing new products and 
services in health. Similar to our results, other studies found that researchers may feel that their work is not 
utilized because of competing interests, lack of funding, or a lack of will on the decision-makers’ part [21]. 
                                                             
4 Strategic plans of the Ministry of Health of the Republic of Croatia. (n. d.). Available online: https://zdravlje.gov.hr/pristup-
informacijama/strategije-planovi-i-izvjesca/strateski-planovi/2672 
  
Other studies also identified numerous barriers to the use of evidence to inform policy such as political 
governance, the bureaucratic process and an overall lack of trust within the system [20]. 
Most of the involved respondents (97.4%) in our survey think that the platform is useful, and all of them are 
aware of the harmful impact that noise can have on health. Even though almost all the respondents have 
recognized the usefulness of the platform, 39.5% would recommend the platform to some people, and 5.3% 
would not recommend it to anyone. Respondents’ personal views might be the reason for such results. 71.1% 
of the respondents said that this approach (EVOTION) is successful in hearing loss prevention and 
management strategy. Despite recognizing the usefulness of the platform, more than half of the respondents 
(58.4%) would not pay to use the EVOTION app, whereas only 5.3% would pay to use it. Although respondents 
did acknowledge the usefulness of the platform, only 7.9% of them would use it more than 50 times in a year. 
Evidence only plays one role (and unfortunately it is sometimes a small one) in the policymaking process and 
external factors, political and institutional forces usually have a stronger role in the policymaking process [2]. 
In conclusion, it is necessary to intensify the education of experts working with health policies and it is also 
suggested to develop lifelong learning curriculums in e-health background for policy-makers. 
5. Conclusion 
In this paper, we present a data-indìformed policymaking platform. To show the potentiality, utility, and 
usability of the platform to the policy-makers, we introduce a scenario based on HL of the EVOTION project 
and then present a walkthrough example of how the policy-makers can utilize machine learning and statistical 
capabilities of the platform in order to design a policy aimed at lower dropout from the HL EVOTION trial. 
Concluding we investigated the views of health system policy-makers involved in the policy development 
process in Croatia on the use of our platform. We presented the relative extensive results on a survey 
conducted on policymaking experts. 
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